Pelvic Floor Muscle Evaluation in Women With Stress Urinary and Urgency Urinary Incontinence
NCT ID: NCT01391780
Last Updated: 2013-12-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
51 participants
OBSERVATIONAL
1997-03-31
1998-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods: 51 women were prospectively divided into two groups, according to the symptoms as SUI (G1 = 22) or UUI (G2 = 29). Demographic data, such as number of Pads/ 24 hours, number of micturitions/ 24 hours and nocturia, delay time of urgent void (i.e., the time period for which an urgent void could be voluntarily postponed), number of parity and vaginal deliveries were obtained using a clinical questionnaire. Objective urine loss was evaluated by 60-min Pad Test. Subjective \[urine stream interruption test (UST), visual survey of perineal contraction and transvaginal digital palpation\] and objective (vaginal manometry) evaluations of PFM were performed in all patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Can Women Correctly Contract Their Pelvic Floor Muscles After to Receive Verbal Instructions and Vaginal Palpation?
NCT03325543
Effects of Training of Pelvic Floor Muscles (MAP) on Stress Urinary Incontinence
NCT03203798
Outpatient and Home Pelvic Floor Training for Stress Urinary Incontinence
NCT03058042
Effectiveness of Pelvic Floor Muscles Training in Group for Women With Urinary Incontinence
NCT03500185
Effect of Pelvic Floor and Hip Muscle Strengthening in the Treatment of Stress Urinary Incontinence
NCT01948713
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Patients with stress urinary incontinence
No interventions assigned to this group
Group 2
Patients with urgency urinary incontinence.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* previous pelvic surgeries
* diabetes
* cognitive difficulties
* vaginal and urinary infection
18 Years
65 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
UPECLIN HC FM Botucatu Unesp
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ethical Research Committee
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
João L. Amaro, PhD, MD
Role: PRINCIPAL_INVESTIGATOR
Universidade Estadual Paulista Júlio de Mesquita Filho
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
São Paulo State University - Medical School of Botucatu
Botucatu, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.